Barclays

Viper Energy Announces Pricing of Secondary Common Stock Offering by Diamondback Energy, Inc.

Retrieved on: 
Wednesday, March 6, 2024
Attention, Goldman Sachs, J.P. Morgan & Co., TPH, Telephone, Scotiabank, Sale, Perella Weinberg Partners, Equity capital markets, Form, Broadridge Financial Solutions, BofA Securities, Roth Capital Partners, Security (finance), Evercore, Barclays, Form S-3

MIDLAND, Texas, March 05, 2024 (GLOBE NEWSWIRE) -- Viper Energy, Inc. (NASDAQ: VNOM) (“Viper”) announced today the pricing of an underwritten public offering of 11,500,000 shares of its Class A common stock (the “Secondary Offering”) by Viper’s parent, Diamondback Energy, Inc. (the “Secondary Stockholder”).

Key Points: 
  • MIDLAND, Texas, March 05, 2024 (GLOBE NEWSWIRE) -- Viper Energy, Inc. (NASDAQ: VNOM) (“Viper”) announced today the pricing of an underwritten public offering of 11,500,000 shares of its Class A common stock (the “Secondary Offering”) by Viper’s parent, Diamondback Energy, Inc. (the “Secondary Stockholder”).
  • The Secondary Offering is expected to close on March 8, 2024, subject to customary closing conditions.
  • J.P. Morgan, Barclays, Evercore ISI and Goldman Sachs & Co. LLC are acting as joint book-running managers for the Secondary Offering.
  • The Secondary Offering may only be made by means of a prospectus supplement and related base prospectus.

Solid Biosciences to Participate at Upcoming Investor Conferences

Retrieved on: 
Wednesday, March 6, 2024
Barclays, SVB Securities, Conference

CHARLESTOWN, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced participation in the following investor conferences:

Key Points: 
  • CHARLESTOWN, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced participation in the following investor conferences:
    Leerink Partners Global Biopharma Conference – Miami, FL
    1x1 meetings on March 11, 2024
    Barclays 26th Annual Global Healthcare Conference – Miami, FL
    Bo Cumbo, Solid’s President and Chief Executive Officer, will present on Wednesday, March 13, 2024, at 1:35 pm ET.
  • A live webcast of the presentation will be available on the Events page of the Investors section of the Company website or by clicking here .
  • A webcast replay will be archived for 30 days on the Events page.
  • Institutional investors interested in meeting with management during the conference may reach out to their Leerink or Barclays representatives.

Ventyx Biosciences to Participate in Two Upcoming Investor Conferences

Retrieved on: 
Wednesday, March 6, 2024
SAN, Barclays, Inflammation

SAN DIEGO, March 06, 2024 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced that Company executives will participate in the following upcoming investor conferences:

Key Points: 
  • SAN DIEGO, March 06, 2024 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced that Company executives will participate in the following upcoming investor conferences:
    A webcast of the Barclays presentation will be available in the Investors and News section of the Ventyx website at www.ventyxbio.com .
  • A webcast replay will also be available on this website shortly after conclusion of the event for thirty days.

FE International Appoints Chris Mayo to Chair New Advisory Board

Retrieved on: 
Wednesday, March 6, 2024
Initial public offering, Advisory board, Schroders, Salomon Brothers, Citigroup, Chair, Barclays, London Stock Exchange Group, Financial services

NEW YORK, March 06, 2024 (GLOBE NEWSWIRE) -- Leading mergers and acquisitions advisory firm for technology businesses, FE International , announces the appointment of Chris Mayo as the Chair of its new Advisory Board.

Key Points: 
  • NEW YORK, March 06, 2024 (GLOBE NEWSWIRE) -- Leading mergers and acquisitions advisory firm for technology businesses, FE International , announces the appointment of Chris Mayo as the Chair of its new Advisory Board.
  • In this role, Chris will leverage his vast experience and industry knowledge to help guide the firm's development and deepen its network.
  • His appointment reflects FE International's commitment to clients in the tech sector.
  • “I am excited to work closely with the team, build out the new Advisory Board in my role as Chair and contribute to the firm's success in facilitating M&A transactions within the technology sector,” said Chris.

Pacira BioSciences to Participate in Fireside Chat at the Barclays 26th Annual Global Healthcare Conference

Retrieved on: 
Wednesday, March 6, 2024
Barclays, Webcast, Conference

TAMPA, Fla., March 06, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the Barclays 26th Annual Global Healthcare Conference at 1:35 PM ET on Wednesday, March 13, 2024 in Miami.

Key Points: 
  • TAMPA, Fla., March 06, 2024 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the Barclays 26th Annual Global Healthcare Conference at 1:35 PM ET on Wednesday, March 13, 2024 in Miami.
  • Live audio of the event can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com .
  • A replay of the webcast will also be available for two weeks following the event.

Viper Energy Launches Secondary Common Stock Offering By Diamondback Energy, Inc.

Retrieved on: 
Tuesday, March 5, 2024
Attention, Goldman Sachs, J.P. Morgan & Co., Telephone, Sale, Equity capital markets, Form, Broadridge Financial Solutions, Security (finance), Evercore, Barclays, Form S-3

MIDLAND, Texas, March 05, 2024 (GLOBE NEWSWIRE) -- Viper Energy, Inc. (NASDAQ: VNOM) (“Viper”) announced today the launch of an underwritten public offering of 11,500,000 shares of its Class A common stock by Viper’s parent, Diamondback Energy, Inc. (the “Selling Stockholder”), subject to market and other conditions (the “Secondary Offering”).

Key Points: 
  • MIDLAND, Texas, March 05, 2024 (GLOBE NEWSWIRE) -- Viper Energy, Inc. (NASDAQ: VNOM) (“Viper”) announced today the launch of an underwritten public offering of 11,500,000 shares of its Class A common stock by Viper’s parent, Diamondback Energy, Inc. (the “Selling Stockholder”), subject to market and other conditions (the “Secondary Offering”).
  • Viper will not receive any proceeds from the sale of the shares by the Selling Stockholder.
  • The Selling Stockholder has also granted the underwriters a 30-day option to purchase up to an additional 1,725,000 shares of Viper’s Class A common stock.
  • J.P. Morgan, Barclays, Evercore ISI and Goldman Sachs & Co. LLC are acting as joint book-running managers for the Secondary Offering.

Replimune to Present at Three Upcoming Investor Conferences

Retrieved on: 
Tuesday, March 5, 2024
Barclays, SVB Securities, REPL

WOBURN, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of a novel class of oncolytic immunotherapies, today announced that members from the Replimune management team will present and host investor meetings at the following three conferences:

Key Points: 
  • WOBURN, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of a novel class of oncolytic immunotherapies, today announced that members from the Replimune management team will present and host investor meetings at the following three conferences:
    Live webcasts of the Leerink and Barclays fireside chats will be available in the Investors section of Replimune’s website at www.replimune.com.
  • A replay will be available for 30 days following the conference.

Profound Medical to Participate in Barclays 26th Annual Global Healthcare Conference

Retrieved on: 
Monday, March 4, 2024
Webcast, TSX, Barclays, Conference

TORONTO, March 04, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that management will participate in a fireside chat at the Barclays 26th Annual Global Healthcare Conference on Wednesday, March 13, 2024 at 11:15 a.m. Eastern Time at the Loews Miami Beach Hotel.

Key Points: 
  • TORONTO, March 04, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that management will participate in a fireside chat at the Barclays 26th Annual Global Healthcare Conference on Wednesday, March 13, 2024 at 11:15 a.m. Eastern Time at the Loews Miami Beach Hotel.
  • The fireside chat will be broadcast live and archived on the Company's website at www.profoundmedical.com under "Webcasts" in the Investors section.

Health Catalyst to Participate in Upcoming Investor Conferences

Retrieved on: 
Monday, March 4, 2024
Senior, FP, Barclays, Conference, HCAT

SALT LAKE CITY, March 04, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that members of leadership will participate in the following upcoming investor conferences:

Key Points: 
  • SALT LAKE CITY, March 04, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that members of leadership will participate in the following upcoming investor conferences:
    The Raymond James 45th Annual Institutional Investors Conference, being held in Orlando, including a fireside chat with Jason Alger, Chief Financial Officer, and Adam Brown, Senior Vice President of FP&A and Investor Relations, on Wednesday, March 6, 2024 at 11:00am ET.
  • The Barclays 26th Annual Global Healthcare Conference, being held in Miami, including a fireside chat with Dan Burton, Chief Executive Officer, and Jason Alger, Chief Financial Officer, on Thursday, March 14, 2024 at 10:15am ET.
  • The webcast link and related presentation materials will be available online at https://ir.healthcatalyst.com .

TC Energy announces sale of Portland Natural Gas Transmission System

Retrieved on: 
Monday, March 4, 2024
Bracewell LLP, Note, Natural gas, TSX, TC Energy, News, Growth, Sale, Debt-to-GDP ratio, TQM, Atlantic Canada, Safety, GAAP, Comparable, BlackRock, TRP, Donald Duck filmography, Barclays, TC, FERC, Bank

PNGTS is a 475-kilometer (295-mile) FERC-regulated transporter of natural gas serving the upper New England and Atlantic Canada markets.

Key Points: 
  • PNGTS is a 475-kilometer (295-mile) FERC-regulated transporter of natural gas serving the upper New England and Atlantic Canada markets.
  • The pipeline receives natural gas from the Trans Quebec and Maritimes (TQM) Pipeline via the Canadian Mainline.
  • TC Energy will provide customary transition services and will work jointly with the Buyer to ensure the safe and orderly transition of this critical natural gas system.
  • Barclays acted as exclusive financial advisor to TC Energy and Énergir on the transaction.